Biotechnology
The Biotechnology industry has a total of 601 stocks, with a combined market cap of $1.14 trillion and total revenue of $105.3 billion.
Market Cap
1.14T
Revenue
105.3B
Profits
-41.63B
PE Ratio
n/a
Profit Margin
-39.54%
Dividend Yield
0.04%
601 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.84B | 3.37% | 1,723,646 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.34B | 4.60% | 1,264,687 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 55.82B | 3.96% | 1,425,993 | 3.21B |
| 4 | ARGX | argenx SE | 50.29B | 2.38% | 491,412 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.54B | 0.53% | 2,179,537 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 36.95B | 4.22% | 510,466 | 4.97B |
| 7 | BNTX | BioNTech SE | 24.06B | 2.03% | 1,051,057 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.89B | 1.82% | 4,005,529 | 2.35B |
| 9 | INCY | Incyte Corporation | 21.71B | 3.67% | 3,377,718 | 4.81B |
| 10 | GMAB | Genmab A/S | 20.87B | 2.42% | 1,556,497 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.86B | 28.63% | 14,855,171 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 15.29B | 1.71% | 7,521,004 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.66B | 1.88% | 2,656,675 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.31B | 0.38% | 2,340,002 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 14.02B | 0.64% | 13,854,475 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.47B | 2.06% | 3,184,551 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.09B | 1.91% | 626,229 | 758.59M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.74B | 0.56% | 402,047 | 740.64M |
| 19 | EXEL | Exelixis, Inc. | 12.43B | 5.75% | 2,543,557 | 2.29B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.78B | 2.06% | 2,210,185 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | 0.17% | 1,650,945 | 20.87M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.29B | 1.43% | 1,645,469 | 4.16B |
| 23 | TECH | Bio-Techne Corporation | 10.14B | -0.35% | 1,311,260 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.97B | 6.20% | 2,119,396 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.93B | -7.23% | 7,163,174 | 829.45M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.83B | 2.71% | 2,684,049 | 1.24B |
| 27 | AXSM | Axsome Therapeutics, Inc. | 8.60B | -0.69% | 814,948 | 561.26M |
| 28 | NUVL | Nuvalent, Inc. | 8.30B | 9.90% | 895,617 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 8.12B | 1.41% | 2,752,936 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.00B | 1.27% | 2,459,093 | 87.21M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.32B | 7.23% | 1,073,339 | 7.46M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.14B | -1.21% | 365,302 | 373.16M |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.97B | - | - | 302.00K |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.78B | 2.18% | 741,116 | 174.33M |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.20B | 0.70% | 1,882,518 | 1.78B |
| 36 | BLTE | Belite Bio, Inc | 6.16B | 2.51% | 535,956 | - |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.14B | 4.40% | 928,457 | 43.74M |
| 38 | PCVX | Vaxcyte, Inc. | 6.03B | 2.70% | 1,520,658 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.53B | -0.34% | 1,900,473 | 38.34M |
| 40 | COGT | Cogent Biosciences, Inc. | 5.52B | 4.28% | 3,437,573 | - |
| 41 | IMVT | Immunovant, Inc. | 5.42B | 3.20% | 1,745,445 | - |
| 42 | APGE | Apogee Therapeutics, Inc. | 5.33B | 0.89% | 1,179,198 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.15B | 0.09% | 1,220,387 | 209.22M |
| 44 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.06B | 16.08% | 4,872,705 | 1.54M |
| 45 | CELC | Celcuity Inc. | 5.05B | 3.95% | 853,190 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.64B | 1.78% | 1,614,008 | 1.05B |
| 47 | GPCR | Structure Therapeutics Inc. | 4.58B | 4.76% | 953,486 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 4.51B | 7.07% | 1,319,121 | - |
| 49 | ADMA | ADMA Biologics, Inc. | 4.48B | 2.62% | 1,985,969 | 488.56M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.44B | 3.16% | 2,174,550 | 531.90M |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.14% | 9,311,733 | 598.70M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.35B | 4.38% | 2,378,094 | - |
| 53 | MIRM | Mirum Pharmaceuticals, Inc. | 4.24B | 7.22% | 668,332 | 471.79M |
| 54 | LEGN | Legend Biotech Corporation | 4.20B | 8.29% | 3,311,463 | 909.05M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.02B | 4.20% | 759,782 | 35.24M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.94B | 2.01% | 181,861 | 251.23M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.89B | 3.41% | 1,851,254 | 741.17M |
| 58 | ACLX | Arcellx, Inc. | 3.76B | 4.75% | 1,211,335 | 35.90M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.66B | 0.25% | 3,879,959 | - |
| 60 | ARQT | Arcutis Biotherapeutics, Inc. | 3.62B | 1.23% | 1,564,254 | 317.93M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.46B | 4.64% | 1,171,542 | - |
| 62 | CGON | CG Oncology, Inc. | 3.42B | 5.15% | 1,157,704 | 2.17M |
| 63 | APLS | Apellis Pharmaceuticals, Inc. | 3.35B | 10.65% | 3,446,396 | 1.02B |
| 64 | IDYA | IDEAYA Biosciences, Inc. | 3.32B | 4.27% | 1,376,968 | 214.83M |
| 65 | CNTA | Centessa Pharmaceuticals plc | 3.31B | 0.04% | 1,824,347 | 15.00M |
| 66 | TARS | Tarsus Pharmaceuticals, Inc. | 3.31B | -2.25% | 729,036 | 366.10M |
| 67 | XENE | Xenon Pharmaceuticals Inc. | 3.25B | 2.73% | 1,299,960 | 7.50M |
| 68 | TVTX | Travere Therapeutics, Inc. | 3.25B | 1.34% | 2,683,001 | 435.83M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.19B | 7.01% | 2,140,854 | - |
| 70 | IRON | Disc Medicine, Inc. | 3.06B | 4.63% | 427,413 | - |
| 71 | NUVB | Nuvation Bio Inc. | 3.03B | 4.12% | 6,122,619 | 26.75M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.92B | -0.49% | 1,775,245 | 70.79M |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.87B | 6.96% | 1,239,333 | 240.00M |
| 74 | BEAM | Beam Therapeutics Inc. | 2.86B | 2.08% | 1,834,651 | 55.70M |
| 75 | WVE | Wave Life Sciences Ltd. | 2.82B | 1.85% | 5,938,799 | 109.23M |
| 76 | MLYS | Mineralys Therapeutics, Inc. | 2.80B | -1.01% | 1,465,722 | - |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.79B | 0.62% | 1,376,142 | 578.20M |
| 78 | LQDA | Liquidia Corporation | 2.70B | 0.88% | 1,530,973 | 69.22M |
| 79 | DNLI | Denali Therapeutics Inc. | 2.65B | -1.51% | 1,877,134 | - |
| 80 | AAPG | Ascentage Pharma Group International | 2.64B | 8.50% | 14,449 | 54.52M |
| 81 | EWTX | Edgewise Therapeutics, Inc. | 2.61B | 7.54% | 1,210,662 | - |
| 82 | ADPT | Adaptive Biotechnologies Corporation | 2.55B | 3.85% | 2,069,328 | 252.75M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.53B | 6.81% | 33,107,461 | 43.69M |
| 84 | TLX | Telix Pharmaceuticals Limited | 2.51B | 0.54% | 142,231 | 664.23M |
| 85 | SRPT | Sarepta Therapeutics, Inc. | 2.46B | 4.97% | 3,293,620 | 2.41B |
| 86 | OCUL | Ocular Therapeutix, Inc. | 2.45B | 2.22% | 2,457,826 | 55.78M |
| 87 | SYRE | Spyre Therapeutics, Inc. | 2.41B | 2.37% | 587,815 | - |
| 88 | SLNO | Soleno Therapeutics, Inc. | 2.38B | -3.79% | 2,015,038 | 98.68M |
| 89 | MESO | Mesoblast Limited | 2.36B | 3.72% | 181,185 | 17.20M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.33B | 7.36% | 4,460,302 | 630.60M |
| 91 | IMNM | Immunome, Inc. | 2.20B | 1.16% | 1,850,532 | 9.68M |
| 92 | IBRX | ImmunityBio, Inc. | 2.17B | 2.80% | 10,050,762 | 82.56M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | 2.18% | 496,798 | 825.94M |
| 94 | GLPG | Galapagos NV | 2.16B | 1.49% | 79,124 | 336.64M |
| 95 | OLMA | Olema Pharmaceuticals, Inc. | 2.13B | 8.11% | 1,738,270 | - |
| 96 | ZLAB | Zai Lab Limited | 2.12B | 4.56% | 1,342,663 | 441.63M |
| 97 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 3.76% | 1,195,737 | 265.81M |
| 98 | VCEL | Vericel Corporation | 2.04B | 2.57% | 1,046,823 | 258.72M |
| 99 | STOK | Stoke Therapeutics, Inc. | 2.01B | -0.14% | 982,420 | 205.63M |
| 100 | MAZE | Maze Therapeutics, Inc. | 1.94B | 5.21% | 334,764 | 2.50M |
| 101 | SION | Sionna Therapeutics, Inc. | 1.93B | 16.09% | 477,263 | - |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.92B | 8.70% | 2,015,114 | 111.30M |
| 103 | NRIX | Nurix Therapeutics, Inc. | 1.87B | 6.08% | 1,734,167 | 83.69M |
| 104 | ALMS | Alumis Inc. | 1.87B | 10.41% | 9,367,771 | 22.12M |
| 105 | ZYME | Zymeworks Inc. | 1.86B | 2.77% | 2,527,800 | 134.48M |
| 106 | CLDX | Celldex Therapeutics, Inc. | 1.84B | 5.63% | 593,044 | 2.60M |
| 107 | MNKD | MannKind Corporation | 1.80B | 4.09% | 5,413,481 | 313.79M |
| 108 | PGEN | Precigen, Inc. | 1.72B | 6.59% | 5,025,082 | 6.31M |
| 109 | IMCR | Immunocore Holdings plc | 1.71B | 2.77% | 340,820 | 379.59M |
| 110 | KOD | Kodiak Sciences Inc. | 1.68B | 8.06% | 983,628 | - |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 3.90% | 1,299,146 | 44.79M |
| 112 | DNTH | Dianthus Therapeutics, Inc. | 1.63B | 5.22% | 722,363 | 3.08M |
| 113 | PHVS | Pharvaris N.V. | 1.63B | 4.12% | 232,368 | - |
| 114 | FTRE | Fortrea Holdings Inc. | 1.62B | -0.29% | 1,488,677 | 2.76B |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.61B | 14.13% | 754,993 | - |
| 116 | TNGX | Tango Therapeutics, Inc. | 1.59B | 21.92% | 7,774,202 | 66.50M |
| 117 | BHVN | Biohaven Ltd. | 1.56B | 22.04% | 6,708,640 | - |
| 118 | UPB | Upstream Bio, Inc. | 1.52B | 8.54% | 700,087 | 2.80M |
| 119 | GLUE | Monte Rosa Therapeutics, Inc. | 1.52B | 45.41% | 23,208,896 | 181.54M |
| 120 | TRVI | Trevi Therapeutics, Inc. | 1.50B | 6.65% | 2,457,031 | - |
| 121 | ERAS | Erasca, Inc. | 1.47B | 42.42% | 41,368,129 | - |
| 122 | MBX | MBX Biosciences, Inc. | 1.46B | 13.41% | 913,603 | - |
| 123 | INVA | Innoviva, Inc. | 1.46B | 1.19% | 536,771 | 388.52M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.45B | 0.95% | 3,797,990 | 6.31M |
| 125 | ATAI | AtaiBeckley Inc. | 1.45B | - | 3,644,029 | 3.02M |
| 126 | EYPT | EyePoint, Inc. | 1.44B | 3.02% | 1,205,300 | 42.34M |
| 127 | QURE | uniQure N.V. | 1.44B | 3.45% | 1,697,081 | 15.75M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.44B | 8.89% | 599,451 | - |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.42B | 0.12% | 2,738,685 | 8.36M |
| 130 | ARDX | Ardelyx, Inc. | 1.42B | 4.86% | 7,215,908 | 398.23M |
| 131 | SVRA | Savara Inc. | 1.39B | 4.15% | 1,444,926 | - |
| 132 | MNMD | Mind Medicine (MindMed) Inc. | 1.38B | 3.85% | 1,916,222 | - |
| 133 | CAPR | Capricor Therapeutics, Inc. | 1.36B | 0.69% | 1,176,729 | 11.13M |
| 134 | ORKA | Oruka Therapeutics, Inc. | 1.35B | 4.47% | 455,561 | - |
| 135 | NBY | NovaBay Pharmaceuticals, Inc. | 1.34B | 43.98% | 3,369,627 | 10.30M |
| 136 | IMTX | Immatics N.V. | 1.32B | 2.50% | 499,999 | 99.45M |
| 137 | PHAT | Phathom Pharmaceuticals, Inc. | 1.29B | 10.45% | 1,099,084 | 147.19M |
| 138 | SANA | Sana Biotechnology, Inc. | 1.26B | 8.49% | 2,845,272 | - |
| 139 | ANAB | AnaptysBio, Inc. | 1.25B | 2.96% | 665,225 | 169.47M |
| 140 | NVAX | Novavax, Inc. | 1.24B | 2.42% | 4,270,616 | 1.06B |
| 141 | ABCL | AbCellera Biologics Inc. | 1.24B | 5.90% | 5,808,418 | 35.33M |
| 142 | OCS | Oculis Holding AG | 1.21B | 0.33% | 127,195 | 992.00K |
| 143 | XERS | Xeris Biopharma Holdings, Inc. | 1.20B | 3.59% | 4,737,870 | 266.14M |
| 144 | PVLA | Palvella Therapeutics, Inc. | 1.20B | 11.72% | 237,121 | - |
| 145 | SEPN | Septerna, Inc. | 1.18B | 3.77% | 304,103 | 22.05M |
| 146 | PHAR | Pharming Group N.V. | 1.18B | 1.90% | 20,495 | 362.27M |
| 147 | NTLA | Intellia Therapeutics, Inc. | 1.17B | 4.11% | 5,085,858 | 57.53M |
| 148 | GHRS | GH Research PLC | 1.11B | 27.12% | 1,836,528 | - |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -0.22% | 161,951 | 1.40M |
| 150 | IOVA | Iovance Biotherapeutics, Inc. | 1.10B | 8.63% | 13,729,357 | 250.43M |
| 151 | SPRY | ARS Pharmaceuticals, Inc. | 1.10B | -0.45% | 1,302,265 | 142.77M |
| 152 | URGN | UroGen Pharma Ltd. | 1.08B | 5.71% | 423,671 | 96.52M |
| 153 | XNCR | Xencor, Inc. | 1.07B | 6.33% | 1,595,302 | 150.13M |
| 154 | NBTX | Nanobiotix S.A. | 1.03B | 5.45% | 92,965 | 11.93M |
| 155 | OMER | Omeros Corporation | 998.99M | 4.14% | 4,289,898 | - |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 987.03M | -0.52% | 1,013,822 | 192.44M |
| 157 | DAWN | Day One Biopharmaceuticals, Inc. | 986.71M | 11.23% | 2,017,103 | 133.67M |
| 158 | VTYX | Ventyx Biosciences, Inc. | 979.75M | 36.62% | 28,072,307 | - |
| 159 | CMPX | Compass Therapeutics, Inc. | 969.35M | 11.00% | 3,104,064 | 850.00K |
| 160 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 967.46M | 4.36% | 1,046,236 | - |
| 161 | TBPH | Theravance Biopharma, Inc. | 956.70M | 3.17% | 648,054 | 80.33M |
| 162 | MDXG | MiMedx Group, Inc. | 953.78M | 0.63% | 732,583 | 393.44M |
| 163 | IVA | Inventiva S.A. | 947.68M | 12.33% | 1,435,178 | 19.93M |
| 164 | BCAX | Bicara Therapeutics Inc. | 940.61M | 6.05% | 876,479 | - |
| 165 | ABUS | Arbutus Biopharma Corporation | 938.54M | 1.88% | 1,569,006 | 14.61M |
| 166 | ELVN | Enliven Therapeutics, Inc. | 918.10M | 2.18% | 774,713 | - |
| 167 | RAPT | RAPT Therapeutics, Inc. | 898.39M | 5.16% | 436,598 | - |
| 168 | ZBIO | Zenas BioPharma, Inc. | 886.24M | 8.62% | 2,041,005 | 15.00M |
| 169 | NKTR | Nektar Therapeutics | 885.06M | 1.26% | 515,790 | 62.60M |
| 170 | CRMD | CorMedix Inc. | 880.07M | -0.80% | 2,476,002 | 214.30M |
| 171 | GERN | Geron Corporation | 874.55M | 3.79% | 7,696,916 | 183.40M |
| 172 | KURA | Kura Oncology, Inc. | 867.56M | 4.51% | 1,925,170 | 104.03M |
| 173 | VIR | Vir Biotechnology, Inc. | 857.01M | 3.36% | 1,995,613 | 16.86M |
| 174 | RIGL | Rigel Pharmaceuticals, Inc. | 853.66M | 8.66% | 812,612 | 282.08M |
| 175 | VALN | Valneva SE | 849.97M | 1.44% | 17,135 | 211.09M |
| 176 | ORIC | ORIC Pharmaceuticals, Inc. | 845.34M | 6.63% | 1,838,202 | - |
| 177 | JANX | Janux Therapeutics, Inc. | 840.87M | 4.02% | 2,192,212 | 10.00M |
| 178 | KALV | KalVista Pharmaceuticals, Inc. | 825.93M | 3.75% | 686,969 | 1.43M |
| 179 | ANNX | Annexon, Inc. | 824.28M | 8.43% | 3,142,227 | - |
| 180 | AVBP | ArriVent BioPharma, Inc. | 810.77M | 3.75% | 410,182 | - |
| 181 | YDES | YD Bio Limited | 808.68M | -1.37% | 115,335 | 510.36K |
| 182 | MLTX | MoonLake Immunotherapeutics | 805.81M | 1.07% | 2,004,573 | - |
| 183 | ARVN | Arvinas, Inc. | 797.02M | 4.90% | 891,068 | 312.30M |
| 184 | RGNX | REGENXBIO Inc. | 771.50M | 7.48% | 866,698 | 161.32M |
| 185 | ATXS | Astria Therapeutics, Inc. | 753.52M | 2.09% | 1,174,979 | 706.00K |
| 186 | DRUG | Bright Minds Biosciences Inc. | 732.74M | 2.98% | 463,780 | - |
| 187 | LXEO | Lexeo Therapeutics, Inc. | 731.33M | 5.36% | 1,027,339 | - |
| 188 | CTMX | CytomX Therapeutics, Inc. | 728.57M | 3.86% | 2,121,420 | 113.63M |
| 189 | PROK | ProKidney Corp. | 728.02M | 7.56% | 1,348,171 | 744.00K |
| 190 | DBVT | DBV Technologies S.A. | 718.59M | 8.18% | 370,656 | 5.50M |
| 191 | PRME | Prime Medicine, Inc. | 715.23M | 9.19% | 4,236,396 | 5.98M |
| 192 | MPLT | MapLight Therapeutics, Inc. | 700.88M | -5.58% | 158,775 | - |
| 193 | REPL | Replimune Group, Inc. | 699.71M | 5.56% | 844,488 | - |
| 194 | IVVD | Invivyd, Inc. | 665.09M | 0.84% | 2,777,689 | 50.04M |
| 195 | GYRE | Gyre Therapeutics, Inc. | 663.95M | 4.81% | 93,619 | 107.27M |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 658.38M | -0.10% | 1,001,422 | 80.00M |
| 197 | CGEM | Cullinan Therapeutics, Inc. | 646.29M | 7.68% | 722,695 | - |
| 198 | MGTX | MeiraGTx Holdings plc | 622.19M | 2.93% | 350,518 | 27.42M |
| 199 | JBIO | Jade Biosciences, Inc. | 606.57M | 0.11% | 399,378 | - |
| 200 | ABSI | Absci Corporation | 604.49M | 3.08% | 4,363,304 | 2.82M |
| 201 | VSTM | Verastem, Inc. | 589.67M | 11.05% | 7,019,675 | 13.38M |
| 202 | SLS | SELLAS Life Sciences Group, Inc. | 575.47M | -1.46% | 14,641,012 | - |
| 203 | ENGN | enGene Holdings Inc. | 569.37M | 2.91% | 188,392 | - |
| 204 | KROS | Keros Therapeutics, Inc. | 565.45M | 4.33% | 494,176 | 246.72M |
| 205 | DSGN | Design Therapeutics, Inc. | 562.23M | 11.90% | 251,096 | - |
| 206 | GOSS | Gossamer Bio, Inc. | 557.81M | -5.86% | 6,879,845 | 44.05M |
| 207 | DNA | Ginkgo Bioworks Holdings, Inc. | 546.20M | 4.80% | 932,821 | 180.61M |
| 208 | IMRX | Immuneering Corporation | 537.87M | 23.96% | 7,877,603 | - |
| 209 | LYEL | Lyell Immunopharma, Inc. | 532.16M | -2.64% | 110,499 | 41.00K |
| 210 | LBRX | LB Pharmaceuticals Inc | 531.03M | 5.53% | 144,148 | - |
| 211 | CRVS | Corvus Pharmaceuticals, Inc. | 530.24M | 6.29% | 1,127,291 | - |
| 212 | NAGE | Niagen Bioscience, Inc. | 526.19M | -2.81% | 918,409 | 124.71M |
| 213 | VOR | Vor Biopharma Inc. | 525.05M | 16.20% | 1,586,340 | - |
| 214 | TENX | Tenax Therapeutics, Inc. | 521.33M | -3.17% | 331,656 | - |
| 215 | VTVT | vTv Therapeutics Inc. | 521.05M | -1.71% | 39,887 | 17.00K |
| 216 | AUTL | Autolus Therapeutics plc | 518.98M | -2.50% | 1,949,003 | 51.13M |
| 217 | EVMN | Evommune, Inc. | 510.69M | 0.75% | 502,801 | 13.00M |
| 218 | LENZ | LENZ Therapeutics, Inc. | 510.34M | -3.20% | 1,226,631 | 17.50M |
| 219 | VNDA | Vanda Pharmaceuticals Inc. | 504.69M | 5.04% | 1,809,101 | 212.07M |
| 220 | DRTS | Alpha Tau Medical Ltd. | 503.06M | 1.03% | 244,668 | - |
| 221 | ANRO | Alto Neuroscience, Inc. | 497.06M | 6.10% | 208,234 | - |
| 222 | KYTX | Kyverna Therapeutics, Inc. | 497.03M | 9.57% | 1,051,278 | - |
| 223 | OCGN | Ocugen, Inc. | 496.59M | 3.25% | 4,622,176 | 5.37M |
| 224 | ASMB | Assembly Biosciences, Inc. | 496.50M | 2.65% | 167,392 | 37.19M |
| 225 | PEPG | PepGen Inc. | 491.55M | 4.53% | 588,968 | - |
| 226 | PRTA | Prothena Corporation plc | 491.47M | 1.78% | 468,687 | 11.79M |
| 227 | ZVRA | Zevra Therapeutics, Inc. | 477.40M | 2.05% | 893,028 | 84.39M |
| 228 | BCYC | Bicycle Therapeutics plc | 476.56M | 4.57% | 270,737 | 28.34M |
| 229 | FBRX | Forte Biosciences, Inc. | 468.97M | 12.11% | 155,755 | - |
| 230 | NBP | NovaBridge Biosciences | 461.16M | 3.09% | 1,575,281 | - |
| 231 | ALT | Altimmune, Inc. | 457.36M | 5.81% | 7,265,066 | 20.00K |
| 232 | ADCT | ADC Therapeutics SA | 452.15M | 3.11% | 819,067 | 75.21M |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 443.94M | 8.07% | 981,131 | 120.00K |
| 234 | LCTX | Lineage Cell Therapeutics, Inc. | 443.46M | 7.65% | 1,720,394 | 10.82M |
| 235 | DMAC | DiaMedica Therapeutics Inc. | 442.14M | -0.35% | 141,989 | - |
| 236 | SLDB | Solid Biosciences Inc. | 437.08M | 2.19% | 637,799 | - |
| 237 | MNPR | Monopar Therapeutics Inc. | 434.43M | 6.45% | 290,578 | - |
| 238 | IMMP | Immutep Limited | 426.13M | 3.40% | 289,152 | 3.31M |
| 239 | LXRX | Lexicon Pharmaceuticals, Inc. | 425.18M | 2.63% | 2,062,235 | 70.86M |
| 240 | RCKT | Rocket Pharmaceuticals, Inc. | 420.98M | 9.89% | 4,544,112 | - |
| 241 | PRTC | PureTech Health plc | 418.11M | 3.63% | 1,890 | 6.39M |
| 242 | BNTC | Benitec Biopharma Inc. | 411.09M | 1.25% | 220,704 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 406.89M | 5.64% | 321,472 | - |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 400.90M | 2.28% | 190,632 | 65.32M |
| 245 | NMRA | Neumora Therapeutics, Inc. | 389.16M | 25.82% | 13,541,112 | - |
| 246 | TRDA | Entrada Therapeutics, Inc. | 385.51M | 6.65% | 166,992 | 61.52M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 374.44M | -3.09% | 70,174 | - |
| 248 | AVXL | Anavex Life Sciences Corp. | 366.33M | 2.24% | 1,600,197 | - |
| 249 | ACIU | AC Immune SA | 364.11M | 7.29% | 471,392 | 5.48M |
| 250 | HELP | Cybin Inc. | 363.30M | -2.15% | 702,758 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 349.75M | 1.01% | 422,095 | 33.98M |
| 252 | GLSI | Greenwich LifeSciences, Inc. | 346.09M | 21.68% | 483,478 | - |
| 253 | AURA | Aura Biosciences, Inc. | 344.82M | 5.23% | 303,639 | - |
| 254 | ZURA | Zura Bio Limited | 343.32M | 9.32% | 745,726 | - |
| 255 | CLLS | Cellectis S.A. | 340.62M | 3.41% | 31,156 | 82.55M |
| 256 | XOMA | XOMA Royalty Corporation | 336.94M | 2.87% | 795,387 | 47.11M |
| 257 | ALLO | Allogene Therapeutics, Inc. | 334.85M | 5.67% | 4,253,653 | 22.00K |
| 258 | CAMP | Camp4 Therapeutics Corporation | 321.66M | 3.51% | 260,486 | 3.80M |
| 259 | MENS | Jyong Biotech Ltd. | 317.60M | 12.84% | 418,085 | - |
| 260 | RLMD | Relmada Therapeutics, Inc. | 316.80M | 5.88% | 601,983 | - |
| 261 | CADL | Candel Therapeutics, Inc. | 311.27M | 1.61% | 527,617 | - |
| 262 | AVTX | Avalo Therapeutics, Inc. | 307.19M | 6.47% | 274,931 | 192.00K |
| 263 | PBYI | Puma Biotechnology, Inc. | 306.88M | 3.92% | 394,417 | 212.00M |
| 264 | TARA | Protara Therapeutics, Inc. | 304.91M | 11.13% | 1,263,684 | - |
| 265 | STTK | Shattuck Labs, Inc. | 303.74M | 20.60% | 1,455,864 | 1.00M |
| 266 | PALI | Palisade Bio, Inc. | 300.99M | 5.21% | 9,697,494 | - |
| 267 | AARD | Aardvark Therapeutics, Inc. | 298.29M | 2.93% | 129,076 | - |
| 268 | FHTX | Foghorn Therapeutics Inc. | 297.46M | 6.69% | 97,954 | 24.52M |
| 269 | NGNE | Neurogene Inc. | 296.16M | 4.48% | 334,110 | 925.00K |
| 270 | LRMR | Larimar Therapeutics, Inc. | 292.72M | 1.48% | 1,309,471 | - |
| 271 | ACRS | Aclaris Therapeutics, Inc. | 290.37M | 1.13% | 1,097,852 | 15.74M |
| 272 | GUTS | Fractyl Health, Inc. | 286.42M | 4.50% | 3,550,808 | 3.00K |
| 273 | ABEO | Abeona Therapeutics Inc. | 282.88M | 1.16% | 1,108,930 | 400.00K |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 280.40M | 18.72% | 553,131 | - |
| 275 | CTNM | Contineum Therapeutics, Inc. | 278.98M | 0.74% | 147,927 | - |
| 276 | ACHV | Achieve Life Sciences, Inc. | 276.82M | 4.21% | 701,014 | - |
| 277 | SLN | Silence Therapeutics plc | 273.96M | 1.22% | 534,997 | 25.83M |
| 278 | OABI | OmniAb, Inc. | 273.52M | 3.26% | 263,248 | 21.09M |
| 279 | AVIR | Atea Pharmaceuticals, Inc. | 271.88M | 2.05% | 326,292 | - |
| 280 | OBIO | Orchestra BioMed Holdings, Inc. | 270.47M | 7.64% | 290,818 | 2.82M |
| 281 | IMMX | Immix Biopharma, Inc. | 266.11M | 2.02% | 1,584,535 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 259.57M | 2.98% | 128,029 | 38.79M |
| 283 | IKT | Inhibikase Therapeutics, Inc. | 258.52M | -5.50% | 570,475 | 1.00 |
| 284 | ALDX | Aldeyra Therapeutics, Inc. | 250.28M | 2.46% | 883,366 | - |
| 285 | MDWD | MediWound Ltd. | 248.35M | 3.09% | 121,078 | 20.93M |
| 286 | ARMP | Armata Pharmaceuticals, Inc. | 243.20M | 13.80% | 33,421 | 5.05M |
| 287 | PRLD | Prelude Therapeutics Incorporated | 233.18M | 10.55% | 976,685 | 10.50M |
| 288 | OVID | Ovid Therapeutics Inc. | 231.73M | 1.14% | 1,752,647 | 6.61M |
| 289 | HUMA | Humacyte, Inc. | 231.60M | 11.11% | 9,930,338 | 1.57M |
| 290 | HRTX | Heron Therapeutics, Inc. | 231.04M | 3.28% | 1,276,318 | 155.10M |
| 291 | GALT | Galectin Therapeutics Inc. | 228.23M | 2.61% | 456,941 | - |
| 292 | PRQR | ProQR Therapeutics N.V. | 227.55M | 3.85% | 734,575 | 18.86M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 227.40M | 1.74% | 400,280 | 31.32M |
| 294 | NVCT | Nuvectis Pharma, Inc. | 225.15M | 7.20% | 70,009 | - |
| 295 | MIST | Milestone Pharmaceuticals Inc. | 218.40M | 4.88% | 5,962,655 | - |
| 296 | RZLT | Rezolute, Inc. | 217.91M | 23.04% | 8,983,085 | - |
| 297 | CRDF | Cardiff Oncology, Inc. | 216.23M | 8.08% | 1,762,067 | 501.00K |
| 298 | CCCC | C4 Therapeutics, Inc. | 215.15M | 9.36% | 2,121,281 | 30.11M |
| 299 | CBIO | Crescent Biopharma, Inc. | 213.87M | -1.17% | 203,886 | - |
| 300 | EDIT | Editas Medicine, Inc. | 210.86M | 0.93% | 2,722,227 | 46.38M |
| 301 | CABA | Cabaletta Bio, Inc. | 206.01M | 4.90% | 2,445,510 | - |
| 302 | NERV | Minerva Neurosciences, Inc. | 203.82M | 9.03% | 189,355 | - |
| 303 | RNAC | Cartesian Therapeutics, Inc. | 201.79M | 10.23% | 181,113 | 1.09M |
| 304 | CLYM | Climb Bio, Inc. | 200.53M | 10.24% | 634,056 | - |
| 305 | ENLV | Enlivex Therapeutics Ltd. | 195.15M | 0.37% | 361,091 | - |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 194.34M | 3.48% | 525,524 | 97.60M |
| 307 | TNXP | Tonix Pharmaceuticals Holding Corp. | 193.68M | 1.76% | 505,831 | 10.30M |
| 308 | ALEC | Alector, Inc. | 192.11M | 4.14% | 1,258,079 | 69.05M |
| 309 | SABS | SAB Biotherapeutics, Inc. | 189.00M | 9.67% | 448,789 | 114.70K |
| 310 | SGMT | Sagimet Biosciences Inc. | 179.52M | 1.10% | 434,821 | - |
| 311 | TLSA | Tiziana Life Sciences Ltd | 178.24M | 1.35% | 216,507 | - |
| 312 | NTHI | NeOnc Technologies Holdings, Inc. | 176.63M | 1.57% | 75,395 | 59.99K |
| 313 | CHRS | Coherus Oncology, Inc. | 172.85M | 5.15% | 976,006 | 277.73M |
| 314 | SRZN | Surrozen, Inc. | 171.17M | 1.53% | 203,075 | 3.60M |
| 315 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | 0.72% | 1,357,852 | 1.20M |
| 316 | IPHA | Innate Pharma S.A. | 167.83M | 1.72% | 5,439 | 14.84M |
| 317 | CRBU | Caribou Biosciences, Inc. | 165.44M | 2.91% | 1,004,623 | 9.30M |
| 318 | KLRS | Kalaris Therapeutics, Inc. | 163.83M | 6.05% | 86,805 | - |
| 319 | QNCX | Quince Therapeutics, Inc. | 162.03M | 4.68% | 905,150 | - |
| 320 | CGEN | Compugen Ltd. | 160.88M | 10.97% | 831,252 | 6.90M |
| 321 | MOLN | Molecular Partners AG | 159.54M | -2.69% | 3,162 | 856.30K |
| 322 | ZNTL | Zentalis Pharmaceuticals, Inc. | 156.70M | 35.96% | 4,673,676 | 26.87M |
| 323 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 156.01M | 4.60% | 142,975 | - |
| 324 | SGMO | Sangamo Therapeutics, Inc. | 154.79M | 3.58% | 5,121,474 | 32.88M |
| 325 | BDTX | Black Diamond Therapeutics, Inc. | 154.40M | 4.23% | 900,427 | 70.00M |
| 326 | CDXS | Codexis, Inc. | 153.55M | -1.16% | 634,076 | 52.93M |
| 327 | CNTX | Context Therapeutics Inc. | 152.52M | 0.61% | 1,752,644 | - |
| 328 | ACTU | Actuate Therapeutics, Inc. | 150.85M | -2.55% | 47,341 | - |
| 329 | SLGL | Sol-Gel Technologies Ltd. | 148.32M | 15.84% | 20,705 | 18.97M |
| 330 | SPRO | Spero Therapeutics, Inc. | 146.48M | 3.59% | 321,577 | 40.55M |
| 331 | NKTX | Nkarta, Inc. | 146.32M | 6.74% | 1,399,334 | - |
| 332 | IRD | Opus Genetics, Inc. | 145.51M | 1.44% | 352,196 | 14.63M |
| 333 | ELTX | Elicio Therapeutics, Inc. | 145.04M | 2.85% | 82,955 | - |
| 334 | MCRB | Seres Therapeutics, Inc. | 143.48M | 1.99% | 28,213 | 351.00K |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 143.15M | 0.56% | 466,731 | 61.84M |
| 336 | ACOG | Alpha Cognition Inc. | 141.32M | 5.18% | 44,278 | 7.43M |
| 337 | CBUS | Cibus, Inc. | 134.62M | 5.98% | 593,375 | 3.79M |
| 338 | TTRX | Turn Therapeutics Inc. | 134.56M | 1.78% | 24,021 | - |
| 339 | KPTI | Karyopharm Therapeutics Inc. | 134.19M | 7.07% | 652,560 | 142.53M |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 133.22M | 7.41% | 4,598,103 | - |
| 341 | FBIO | Fortress Biotech, Inc. | 132.53M | 1.43% | 870,994 | 62.30M |
| 342 | CNTB | Connect Biopharma Holdings Limited | 131.37M | 3.98% | 21,140 | 762.00K |
| 343 | CGTX | Cognition Therapeutics, Inc. | 130.65M | 4.96% | 1,848,604 | - |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 130.15M | 6.51% | 376,841 | 2.00M |
| 345 | VRCA | Verrica Pharmaceuticals Inc. | 129.84M | 0.87% | 189,985 | 30.83M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 129.16M | 6.37% | 464,610 | - |
| 347 | ELDN | Eledon Pharmaceuticals, Inc. | 128.50M | 3.01% | 1,020,762 | - |
| 348 | FATE | Fate Therapeutics, Inc. | 128.04M | 9.90% | 2,197,343 | 7.14M |
| 349 | GNLX | Genelux Corporation | 127.53M | - | 322,071 | 8.00K |
| 350 | WHWK | Whitehawk Therapeutics, Inc. | 125.83M | 5.95% | 114,843 | 14.38M |
| 351 | AGEN | Agenus Inc. | 125.83M | 6.63% | 955,315 | 106.83M |
| 352 | HYFT | MindWalk Holdings Corp. | 124.67M | 15.09% | 1,075,013 | 19.02M |
| 353 | ABOS | Acumen Pharmaceuticals, Inc. | 120.54M | 1.53% | 220,170 | - |
| 354 | INO | Inovio Pharmaceuticals, Inc. | 114.73M | 4.37% | 1,891,567 | 182.34K |
| 355 | MGNX | MacroGenics, Inc. | 114.50M | 6.47% | 1,763,461 | 127.63M |
| 356 | IPSC | Century Therapeutics, Inc. | 113.51M | 44.44% | 5,874,124 | 113.34M |
| 357 | ARTV | Artiva Biotherapeutics, Inc. | 112.91M | 4.31% | 281,423 | 251.00K |
| 358 | RPTX | Repare Therapeutics Inc. | 110.36M | -0.39% | 971,139 | 11.87M |
| 359 | THAR | Tharimmune, Inc. | 109.70M | -2.59% | 354,764 | - |
| 360 | ANIX | Anixa Biosciences, Inc. | 107.97M | 3.14% | 181,339 | - |
| 361 | ANVS | Annovis Bio, Inc. | 107.87M | 5.71% | 654,834 | - |
| 362 | COYA | Coya Therapeutics, Inc. | 107.76M | -1.90% | 340,160 | 3.99M |
| 363 | ATRA | Atara Biotherapeutics, Inc. | 107.72M | 2.54% | 254,905 | 151.93M |
| 364 | SEER | Seer, Inc. | 106.32M | 3.28% | 169,036 | 16.38M |
| 365 | DWTX | Dogwood Therapeutics, Inc. | 105.83M | -10.33% | 99,080 | - |
| 366 | SAVA | Cassava Sciences, Inc. | 105.31M | 2.83% | 1,093,715 | - |
| 367 | DTIL | Precision BioSciences, Inc. | 104.95M | 3.56% | 415,008 | 698.00K |
| 368 | ONCY | Oncolytics Biotech Inc. | 103.37M | -0.44% | 380,600 | - |
| 369 | VXRT | Vaxart, Inc. | 103.16M | 10.37% | - | 148.20M |
| 370 | STRO | Sutro Biopharma, Inc. | 100.10M | 2.00% | 123,976 | 105.65M |
| 371 | ETHZ | ETHZilla Corporation | 94.68M | -3.10% | 766,641 | 4.11M |
| 372 | VANI | Vivani Medical, Inc. | 94.11M | 2.38% | 127,728 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 94.04M | 5.56% | 898,445 | - |
| 374 | CSBR | Champions Oncology, Inc. | 93.73M | 2.12% | 4,180 | 58.42M |
| 375 | ACRV | Acrivon Therapeutics, Inc. | 93.09M | -1.99% | 3,047,714 | - |
| 376 | GANX | Gain Therapeutics, Inc. | 92.69M | -5.49% | 1,518,795 | - |
| 377 | PYXS | Pyxis Oncology, Inc. | 88.42M | 9.23% | 2,076,617 | 2.82M |
| 378 | PTHS | Pelthos Therapeutics Inc. | 86.43M | 2.04% | 21,644 | 7.41M |
| 379 | ATOS | Atossa Therapeutics, Inc. | 85.91M | 0.71% | 668,105 | - |
| 380 | ACET | Adicet Bio, Inc. | 85.40M | 4.97% | 116,871 | - |
| 381 | OKYO | OKYO Pharma Limited | 84.62M | 6.13% | 58,828 | - |
| 382 | SPRB | Spruce Biosciences, Inc. | 83.59M | -3.08% | 32,862 | 697.00K |
| 383 | PSTV | Plus Therapeutics, Inc. | 83.53M | 8.34% | 3,812,452 | 5.26M |
| 384 | CALC | CalciMedica, Inc. | 83.29M | 1.23% | 43,647 | - |
| 385 | EXOZ | eXoZymes, Inc. | 83.03M | -2.37% | 7,427 | -700.00 |
| 386 | IMUX | Immunic, Inc. | 83.00M | 10.67% | 2,852,087 | - |
| 387 | PLRX | Pliant Therapeutics, Inc. | 82.96M | 5.47% | 956,158 | - |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 81.44M | 0.53% | 104,529 | 501.00K |
| 389 | IFRX | InflaRx N.V. | 81.30M | 2.56% | 395,754 | 73.73K |
| 390 | KRRO | Korro Bio, Inc. | 79.95M | 2.78% | 281,414 | 7.37M |
| 391 | EQ | Equillium, Inc. | 79.77M | 1.55% | 626,432 | 4.39M |
| 392 | PYPD | PolyPid Ltd. | 79.18M | 4.16% | 82,770 | - |
| 393 | ADAG | Adagene Inc. | 79.18M | -7.69% | 67,766 | 103.20K |
| 394 | TVGN | Tevogen Bio Holdings Inc. | 76.75M | 10.66% | 589,855 | - |
| 395 | XBIT | XBiotech Inc. | 76.52M | -0.79% | 75,556 | - |
| 396 | CRVO | CervoMed Inc. | 73.56M | 5.30% | 29,663 | 6.16M |
| 397 | ATYR | aTyr Pharma, Inc. | 73.15M | 3.07% | 1,255,657 | 190.00K |
| 398 | ENTX | Entera Bio Ltd. | 72.91M | 1.27% | 240,355 | 124.00K |
| 399 | KZIA | Kazia Therapeutics Limited | 72.79M | 1.83% | 230,969 | 1.20M |
| 400 | NRXP | NRx Pharmaceuticals, Inc. | 72.53M | 2.51% | 357,670 | 242.00K |
| 401 | IMA | ImageneBio, Inc. | 72.11M | 2.27% | 5,257 | 800.00K |
| 402 | MNOV | MediciNova, Inc. | 68.80M | 1.45% | 37,591 | 257.92K |
| 403 | MGX | Metagenomi, Inc. | 67.58M | 3.45% | 283,192 | 30.91M |
| 404 | MREO | Mereo BioPharma Group plc | 67.12M | 11.29% | 20,628,347 | 500.00K |
| 405 | TCRX | TScan Therapeutics, Inc. | 66.96M | 3.51% | 787,788 | 8.42M |
| 406 | ATHE | Alterity Therapeutics Limited | 65.82M | - | 6,444 | 3.57M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 65.72M | 1.23% | 218,853 | - |
| 408 | ALXO | ALX Oncology Holdings Inc. | 63.98M | 9.26% | 164,705 | - |
| 409 | BYSI | BeyondSpring Inc. | 62.92M | 2.00% | 99,816 | 1.88M |
| 410 | MAIA | MAIA Biotechnology, Inc. | 62.37M | 6.54% | 317,730 | - |
| 411 | ALGS | Aligos Therapeutics, Inc. | 59.38M | 10.16% | 64,526 | 2.65M |
| 412 | INKT | MiNK Therapeutics, Inc. | 59.22M | 4.78% | 14,868 | - |
| 413 | GRCE | Grace Therapeutics, Inc. | 57.72M | 2.75% | 90,751 | - |
| 414 | JSPR | Jasper Therapeutics, Inc. | 57.37M | 7.89% | 897,234 | - |
| 415 | PASG | Passage Bio, Inc. | 57.34M | -2.28% | 100,770 | - |
| 416 | RADX | Radiopharm Theranostics Limited | 57.20M | 1.25% | 74,589 | 8.20M |
| 417 | ICCC | ImmuCell Corporation | 56.45M | -1.73% | 36,846 | 27.77M |
| 418 | NTRB | Nutriband Inc. | 55.07M | 2.72% | 13,868 | 2.28M |
| 419 | ABVC | ABVC BioPharma, Inc. | 54.45M | 1.76% | 44,552 | 797.92K |
| 420 | ESLA | Estrella Immunopharma, Inc. | 54.38M | 5.11% | 54,430 | - |
| 421 | OSTX | OS Therapies Incorporated | 53.88M | 3.38% | 646,413 | - |
| 422 | ANL | Adlai Nortye Ltd. | 52.77M | -2.05% | 104,880 | -1.35M |
| 423 | IBO | Impact BioMedical Inc. | 52.52M | -5.28% | 24,696 | 25.00K |
| 424 | LITS | Lite Strategy, Inc. | 52.24M | -7.79% | 344,473 | - |
| 425 | PDSB | PDS Biotechnology Corporation | 52.15M | 5.00% | 501,590 | - |
| 426 | TELO | Telomir Pharmaceuticals, Inc. | 50.37M | 1.03% | 86,829 | - |
| 427 | ANEB | Anebulo Pharmaceuticals, Inc. | 49.71M | 4.31% | 28,308 | - |
| 428 | NXTC | NextCure, Inc. | 49.01M | 7.62% | 51,966 | - |
| 429 | IBIO | iBio, Inc. | 48.80M | 5.34% | 4,534,892 | 500.00K |
| 430 | TIL | Instil Bio, Inc. | 48.69M | 7.81% | 855,436 | - |
| 431 | CVM | CEL-SCI Corporation | 47.93M | -9.38% | 69,045 | - |
| 432 | NRXS | NeurAxis, Inc. | 47.30M | -0.45% | 46,126 | 3.36M |
| 433 | PTN | Palatin Technologies, Inc. | 47.18M | -0.80% | 59,313 | 8.85M |
| 434 | KZR | Kezar Life Sciences, Inc. | 46.14M | 0.80% | 14,683 | - |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 45.55M | 2.10% | 68,405 | 90.00K |
| 436 | HURA | TuHURA Biosciences, Inc. | 45.36M | 2.93% | 231,188 | - |
| 437 | IOBT | IO Biotech, Inc. | 45.18M | -1.78% | 583,354 | - |
| 438 | EVAX | Evaxion A/S | 44.95M | 6.73% | 51,273 | 7.65M |
| 439 | APLM | Apollomics, Inc. | 44.64M | 2.72% | 31,530 | 6.93M |
| 440 | INMB | INmune Bio, Inc. | 42.00M | 1.28% | 283,102 | 50.00K |
| 441 | LPCN | Lipocine Inc. | 41.75M | - | 74,077 | 4.32M |
| 442 | QTTB | Q32 Bio Inc. | 40.97M | -1.19% | 189,977 | - |
| 443 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 40.45M | 7.15% | 5,613,376 | - |
| 444 | FGEN | FibroGen, Inc. | 39.28M | 7.65% | 33,990 | 8.30M |
| 445 | OKUR | OnKure Therapeutics, Inc. | 38.21M | 1.44% | 75,577 | - |
| 446 | LTRN | Lantern Pharma Inc. | 38.14M | -1.16% | 47,306 | - |
| 447 | VERU | Veru Inc. | 38.04M | 1.72% | 71,811 | 16.89M |
| 448 | OTLK | Outlook Therapeutics, Inc. | 37.83M | 11.43% | 15,233,290 | 1.41M |
| 449 | XCUR | Exicure, Inc. | 37.10M | -1.19% | 47,620 | 500.00K |
| 450 | XLO | Xilio Therapeutics, Inc. | 37.02M | 1.45% | 383,016 | 31.80M |
| 451 | RNXT | RenovoRx, Inc. | 37.02M | -0.98% | 234,067 | 928.00K |
| 452 | GBIO | Generation Bio Co. | 36.86M | 1.67% | 43,173 | 15.27M |
| 453 | MRKR | Marker Therapeutics, Inc. | 36.51M | 17.74% | 1,097,508 | 4.69M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 36.49M | -1.02% | 87,622 | - |
| 455 | JUNS | Jupiter Neurosciences, Inc. | 35.98M | -0.95% | 28,339 | - |
| 456 | SKYE | Skye Bioscience, Inc. | 35.58M | 9.90% | 873,698 | - |
| 457 | CELU | Celularity Inc. | 35.31M | -0.80% | 24,228 | 40.58M |
| 458 | CUE | Cue Biopharma, Inc. | 35.31M | 5.42% | 828,252 | 7.10M |
| 459 | DYAI | Dyadic International, Inc. | 35.09M | 4.28% | 22,304 | 3.34M |
| 460 | LIXT | Lixte Biotechnology Holdings, Inc. | 34.33M | 10.67% | 175,475 | - |
| 461 | CING | Cingulate Inc. | 33.58M | 6.20% | 188,831 | - |
| 462 | GLTO | Galecto, Inc. | 33.50M | -3.85% | 33,916 | - |
| 463 | GNTA | Genenta Science S.p.A. | 33.04M | -1.40% | 48,922 | - |
| 464 | RNTX | Rein Therapeutics Inc. | 32.33M | 0.82% | 107,946 | - |
| 465 | HOWL | Werewolf Therapeutics, Inc. | 31.13M | -0.12% | 208,788 | 1.14M |
| 466 | SNTI | Senti Biosciences, Inc. | 30.23M | 4.55% | 285,120 | - |
| 467 | RLYB | Rallybio Corporation | 30.23M | 5.39% | 126,758 | 674.00K |
| 468 | ANTX | AN2 Therapeutics, Inc. | 30.14M | 2.80% | 68,760 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 29.60M | 2.10% | 46,059 | 14.97M |
| 470 | HYPD | Hyperion DeFi, Inc. | 29.09M | -7.53% | 170,238 | 345.32K |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 29.08M | 2.05% | 1,603,361 | 721.00K |
| 472 | QNTM | Quantum BioPharma Ltd. | 28.99M | 8.42% | 71,974 | - |
| 473 | ATHA | Athira Pharma, Inc. | 28.91M | 5.47% | 86,138 | - |
| 474 | BOLD | Boundless Bio, Inc. | 28.65M | 4.07% | 236,562 | - |
| 475 | IGC | IGC Pharma, Inc. | 28.56M | 6.40% | 995,613 | 1.11M |
| 476 | DARE | Daré Bioscience, Inc. | 28.15M | 0.51% | 95,815 | -57.13K |
| 477 | PLUR | Pluri Inc. | 27.49M | 2.05% | 7,732 | 1.33M |
| 478 | SER | Serina Therapeutics, Inc. | 25.81M | 16.35% | 904,109 | 116.00K |
| 479 | LIMN | Liminatus Pharma, Inc. | 25.43M | 41.27% | 802,464 | - |
| 480 | BCAB | BioAtla, Inc. | 25.04M | -1.49% | 1,216,851 | 11.00M |
| 481 | NRSN | NeuroSense Therapeutics Ltd. | 24.78M | -4.21% | 106,740 | - |
| 482 | KLTO | Klotho Neurosciences, Inc. | 24.54M | 3.65% | 620,265 | - |
| 483 | PLRZ | Polyrizon Ltd. | 24.43M | -6.81% | 63,976 | - |
| 484 | NNVC | NanoViricides, Inc. | 24.21M | -3.13% | 121,861 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 24.04M | 1.32% | 894,605 | - |
| 486 | FBLG | FibroBiologics, Inc. | 22.88M | 32.27% | 5,965,171 | - |
| 487 | LNAI | Lunai Bioworks Inc. | 22.26M | 3.28% | 320,519 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 21.73M | -10.19% | 693,262 | - |
| 489 | NEUP | Neuphoria Therapeutics Inc. | 21.35M | -0.25% | 25,363 | 15.65M |
| 490 | ALLR | Allarity Therapeutics, Inc. | 20.14M | 4.50% | 154,088 | - |
| 491 | MTVA | MetaVia Inc. | 19.31M | 8.27% | 53,373 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 19.20M | -5.63% | 229,995 | - |
| 493 | ITRM | Iterum Therapeutics plc | 18.95M | 2.51% | 656,639 | 390.00K |
| 494 | CLGN | CollPlant Biotechnologies Ltd. | 18.65M | 0.69% | 12,965 | 2.48M |
| 495 | LSTA | Lisata Therapeutics, Inc. | 18.61M | 8.21% | 53,546 | 1.07M |
| 496 | VYNE | VYNE Therapeutics Inc. | 18.52M | 0.51% | 402,877 | 524.00K |
| 497 | PMN | ProMIS Neurosciences, Inc. | 17.78M | 7.43% | 16,983 | - |
| 498 | CASI | CASI Pharmaceuticals, Inc. | 17.75M | 1.65% | 8,232 | 26.85M |
| 499 | CVKD | Cadrenal Therapeutics, Inc. | 17.44M | 7.65% | 70,258 | - |
| 500 | LEXX | Lexaria Bioscience Corp. | 17.37M | -0.41% | 203,444 | 705.92K |
| 501 | KAPA | Kairos Pharma, Ltd. | 17.28M | 4.92% | 75,142 | - |
| 502 | GRDX | GridAI Technologies Corp. | 16.57M | 7.17% | 179,515 | - |
| 503 | APLT | Applied Therapeutics, Inc. | 16.24M | 0.47% | 7,164,524 | 1.00M |
| 504 | OSRH | OSR Holdings, Inc. | 16.15M | 4.83% | 335,329 | -90.52K |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.13M | - | 65,835 | - |
| 506 | GDTC | CytoMed Therapeutics Limited | 16.04M | - | 8,404 | 573.19K |
| 507 | KALA | KALA BIO, Inc. | 15.46M | 0.99% | 3,695,181 | - |
| 508 | COCP | Cocrystal Pharma, Inc. | 15.16M | 0.46% | 46,559 | - |
| 509 | NCNA | NuCana plc | 15.07M | -2.16% | 48,945 | - |
| 510 | SNGX | Soligenix, Inc. | 14.73M | 3.55% | 76,040 | 2.34K |
| 511 | SNSE | Sensei Biotherapeutics, Inc. | 14.15M | 3.12% | 43,165 | - |
| 512 | CLRB | Cellectar Biosciences, Inc. | 14.08M | 3.11% | 13,641 | - |
| 513 | AEON | AEON Biopharma, Inc. | 13.97M | -4.84% | 168,889 | - |
| 514 | BCDA | BioCardia, Inc. | 13.90M | 3.15% | 105,678 | 3.00K |
| 515 | TPST | Tempest Therapeutics, Inc. | 13.85M | -0.35% | 47,065 | - |
| 516 | SYBX | Synlogic, Inc. | 13.80M | -0.84% | 6,528 | 8.00K |
| 517 | ASBP | Aspire Biopharma Holdings, Inc. | 13.50M | 19.62% | 510,571,831 | 1.94K |
| 518 | BCTX | BriaCell Therapeutics Corp. | 13.48M | -0.56% | 66,693 | - |
| 519 | LGVN | Longeveron Inc. | 13.18M | 5.30% | 192,754 | 1.44M |
| 520 | AKTX | Akari Therapeutics, Plc | 13.16M | -0.90% | 346,025 | - |
| 521 | PHIO | Phio Pharmaceuticals Corp. | 13.02M | 5.22% | 437,821 | - |
| 522 | EDSA | Edesa Biotech, Inc. | 12.83M | 3.36% | 42,087 | - |
| 523 | MBRX | Moleculin Biotech, Inc. | 12.53M | -1.21% | 166,440 | - |
| 524 | BLRX | BioLineRx Ltd. | 12.35M | -0.68% | 8,550 | 12.74M |
| 525 | ABP | Abpro Holdings, Inc. | 12.09M | -8.25% | 17,894 | 183.00K |
| 526 | IMNN | Imunon, Inc. | 12.04M | -0.76% | 37,030 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 11.69M | 4.97% | 41,297 | - |
| 528 | INAB | IN8bio, Inc. | 11.59M | 1.21% | 105,487 | - |
| 529 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.54M | -1.29% | 56,888 | - |
| 530 | BOLT | Bolt Biotherapeutics, Inc. | 11.38M | 0.85% | 12,376 | 5.20M |
| 531 | CRIS | Curis, Inc. | 10.86M | -15.97% | 15,360,558 | 11.65M |
| 532 | TRAW | Traws Pharma, Inc. | 10.71M | 3.08% | 25,172 | 2.85M |
| 533 | NCEL | NewcelX Ltd. | 10.53M | -0.86% | 36,969 | - |
| 534 | BRTX | BioRestorative Therapies, Inc. | 10.47M | 0.85% | 12,591 | 383.40K |
| 535 | BIVI | BioVie Inc. | 10.18M | -2.88% | 113,159 | - |
| 536 | EVGN | Evogene Ltd. | 10.13M | -0.87% | 39,765 | 8.02M |
| 537 | ERNA | Ernexa Therapeutics Inc. | 9.73M | -2.36% | 175,181 | 1,000.00 |
| 538 | ALZN | Alzamend Neuro, Inc. | 8.90M | 9.86% | 124,348 | - |
| 539 | ICU | SeaStar Medical Holding Corporation | 8.87M | - | 131,043 | 881.00K |
| 540 | GOVX | GeoVax Labs, Inc. | 8.74M | -6.39% | 1,492,198 | 3.35M |
| 541 | APM | Aptorum Group Limited | 8.63M | 0.95% | 24,799 | - |
| 542 | CLDI | Calidi Biotherapeutics, Inc. | 8.49M | 0.87% | 48,758 | - |
| 543 | PMCB | PharmaCyte Biotech, Inc. | 8.41M | 7.51% | 1,035,060 | - |
| 544 | PULM | Pulmatrix, Inc. | 8.40M | - | 9,887 | 3.00K |
| 545 | CELZ | Creative Medical Technology Holdings, Inc. | 8.35M | 7.17% | 112,661 | 6.00K |
| 546 | APVO | Aptevo Therapeutics Inc. | 8.34M | 12.01% | 120,666 | - |
| 547 | MBIO | Mustang Bio, Inc. | 8.25M | 3.67% | 63,038 | - |
| 548 | KPRX | Kiora Pharmaceuticals, Inc. | 8.03M | 3.30% | 26,378 | 20.00K |
| 549 | GTBP | GT Biopharma, Inc. | 7.79M | -7.77% | 1,157,697 | - |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 7.78M | 1.63% | 86,447 | - |
| 551 | IMRN | Immuron Limited | 7.66M | 3.61% | 46,277 | 4.78M |
| 552 | TOVX | Theriva Biologics, Inc. | 7.51M | -8.20% | 5,208,241 | - |
| 553 | ADXN | Addex Therapeutics Ltd | 7.49M | -1.85% | 8,667 | 198.82K |
| 554 | TCRT | Alaunos Therapeutics, Inc. | 7.23M | 1.25% | 15,187 | 6.00K |
| 555 | XTLB | XTL Biopharmaceuticals Ltd. | 7.16M | -4.06% | 53,141 | 968.00K |
| 556 | PPBT | Purple Biotech Ltd | 7.03M | 0.19% | 124,753 | - |
| 557 | CYCN | Cyclerion Therapeutics, Inc. | 6.85M | -7.69% | 2,313,068 | 2.86M |
| 558 | RNAZ | TransCode Therapeutics, Inc. | 6.85M | 1.49% | 62,685 | - |
| 559 | PPCB | Propanc Biopharma, Inc. | 6.83M | 0.89% | 107,091 | - |
| 560 | BGMS | Bio Green Med Solution, Inc. | 6.62M | -0.74% | 16,491 | 81.00K |
| 561 | SLXN | Silexion Therapeutics Corp | 6.57M | -0.47% | 13,404 | - |
| 562 | LYRA | Lyra Therapeutics, Inc. | 6.41M | 7.44% | 22,536 | 600.00K |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 6.32M | -3.85% | 548,719 | - |
| 564 | APRE | Aprea Therapeutics, Inc. | 6.29M | -1.32% | 55,723 | 488.24K |
| 565 | ACXP | Acurx Pharmaceuticals, Inc. | 6.07M | -0.34% | 171,911 | - |
| 566 | VIVS | VivoSim Labs, Inc. | 5.82M | 9.31% | 106,414 | 140.00K |
| 567 | CANF | Can-Fite BioPharma Ltd. | 5.51M | - | 204,821 | 560.00K |
| 568 | REVB | Revelation Biosciences, Inc. | 5.39M | -1.08% | 159,015 | - |
| 569 | SLRX | Salarius Pharmaceuticals, Inc. | 5.36M | 29.23% | 6,045,610 | - |
| 570 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.09M | -5.58% | 20,300,571 | 15.78K |
| 571 | SILO | Silo Pharma, Inc. | 5.09M | 0.61% | 84,820 | 72.10K |
| 572 | XBIO | Xenetic Biosciences, Inc. | 4.97M | 2.54% | 7,287 | 2.86M |
| 573 | SPRC | SciSparc Ltd. | 4.95M | 2.72% | 172,872 | 1.31M |
| 574 | JAGX | Jaguar Health, Inc. | 4.95M | -3.54% | 157,057 | 11.79M |
| 575 | INDP | Indaptus Therapeutics, Inc. | 4.71M | 3.86% | 325,835 | - |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 4.57M | 1.46% | 74,306 | - |
| 577 | GNPX | Genprex, Inc. | 4.38M | - | 1,043,266 | - |
| 578 | MTNB | Matinas BioPharma Holdings, Inc. | 4.29M | 12.02% | 19,774 | - |
| 579 | ENVB | Enveric Biosciences, Inc. | 4.25M | 2.72% | 18,932 | - |
| 580 | XRTX | XORTX Therapeutics Inc. | 4.13M | - | 25,507 | - |
| 581 | ENSC | Ensysce Biosciences, Inc. | 3.89M | 5.94% | 109,166 | 4.49M |
| 582 | CMND | Clearmind Medicine Inc. | 3.82M | -5.20% | 48,812 | - |
| 583 | OGEN | Oragenics, Inc. | 3.67M | 1.17% | 11,201 | - |
| 584 | CNSP | CNS Pharmaceuticals, Inc. | 3.44M | 4.53% | 9,739 | - |
| 585 | HCWB | HCW Biologics Inc. | 3.38M | 4.17% | 46,756 | 422.03K |
| 586 | PHGE | BiomX Inc. | 3.30M | -2.70% | 29,006 | - |
| 587 | AZTR | Azitra, Inc. | 3.27M | 6.85% | 542,770 | 7.50K |
| 588 | ARTL | Artelo Biosciences, Inc. | 3.13M | 18.32% | 113,108 | - |
| 589 | GRI | GRI Bio, Inc. | 3.02M | -1.29% | 1,161,666 | - |
| 590 | ONCO | Onconetix, Inc. | 2.83M | 4.00% | 70,073 | 1.22M |
| 591 | BBLG | Bone Biologics Corporation | 2.82M | 1.29% | 41,800 | - |
| 592 | VRAX | Virax Biolabs Group Limited | 2.65M | -3.87% | 555,307 | 2.99K |
| 593 | DRMA | Dermata Therapeutics, Inc. | 2.56M | -3.54% | 108,651 | - |
| 594 | SCNI | Scinai Immunotherapeutics Ltd. | 2.55M | -3.22% | 7,757 | 1.15M |
| 595 | CDT | CDT Equity Inc. | 2.41M | -1.99% | 67,739 | - |
| 596 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.09M | -4.31% | 340,538 | 1.36M |
| 597 | BDRX | Biodexa Pharmaceuticals Plc | 2.03M | -1.22% | 102,490 | 104.90K |
| 598 | ADTX | Aditxt, Inc. | 1.49M | -4.77% | 222,737 | 5.95K |
| 599 | PBM | Psyence Biomedical Ltd. | 1.48M | 7.48% | 273,022 | - |
| 600 | ELAB | PMGC Holdings Inc. | 1.08M | 3.38% | 1,518,829 | 285.95K |
| 601 | MLEC | Moolec Science SA | 1.07M | - | 38,486 | 7.83M |